Extrawell Pharmaceutical Holdings Limited (0858.HK)

HKD 0.05

(2.04%)

Revenue Summary of Extrawell Pharmaceutical Holdings Limited

  • Extrawell Pharmaceutical Holdings Limited's latest annual revenue in 2023 was 59.09 Million HKD , down -18.57% from previous year.
  • Extrawell Pharmaceutical Holdings Limited's latest quarterly revenue in 2023 FY was 59.09 Million HKD , down -18.57% from previous quarter.
  • Extrawell Pharmaceutical Holdings Limited reported a annual revenue of 72.57 Million HKD in annual revenue 2022, down -1.82% from previous year.
  • Extrawell Pharmaceutical Holdings Limited reported a annual revenue of 73.92 Million HKD in annual revenue 2021, down -6.19% from previous year.
  • Extrawell Pharmaceutical Holdings Limited reported a quarterly revenue of 30.14 Million HKD for 2023 Q2, down 0.0% from previous quarter.
  • Extrawell Pharmaceutical Holdings Limited reported a quarterly revenue of 28.95 Million HKD for 2023 Q4, down 0.0% from previous quarter.

Annual Revenue Chart of Extrawell Pharmaceutical Holdings Limited (2023 - 1999)

Historical Annual Revenue of Extrawell Pharmaceutical Holdings Limited (2023 - 1999)

Year Revenue Revenue Growth
2023 59.09 Million HKD -18.57%
2022 72.57 Million HKD -1.82%
2021 73.92 Million HKD -6.19%
2020 78.8 Million HKD 1.57%
2019 77.58 Million HKD -13.04%
2018 89.21 Million HKD 4.03%
2017 85.76 Million HKD -20.52%
2016 107.9 Million HKD -24.12%
2015 142.2 Million HKD 10.38%
2014 128.83 Million HKD -14.49%
2013 150.67 Million HKD -0.26%
2012 151.06 Million HKD -4.03%
2011 157.4 Million HKD -20.83%
2010 198.81 Million HKD 1.29%
2009 196.29 Million HKD 6.43%
2008 184.43 Million HKD 11.72%
2007 165.07 Million HKD 3.98%
2006 158.76 Million HKD -10.94%
2005 178.26 Million HKD 5.01%
2004 169.76 Million HKD -21.27%
2003 215.63 Million HKD 0.05%
2002 215.52 Million HKD 8.03%
2001 199.49 Million HKD 47.6%
2000 135.15 Million HKD 6.44%
1999 126.97 Million HKD 0.0%

Peer Revenue Comparison of Extrawell Pharmaceutical Holdings Limited

Name Revenue Revenue Difference
Pak Fah Yeow International Limited 259.15 Million HKD 77.196%
Grand Pharmaceutical Group Limited 10.52 Billion HKD 99.439%
Wai Yuen Tong Medicine Holdings Limited 783.88 Million HKD 92.461%
Qianhai Health Holdings Limited 961.29 Million HKD 93.852%
Lee's Pharmaceutical Holdings Limited 1.05 Billion HKD 94.388%
Essex Bio-Technology Limited 1.7 Billion HKD 96.537%
Tongfang Kontafarma Holdings Limited 809.1 Million HKD 92.696%
PuraPharm Corporation Limited 406.85 Million HKD 85.475%
SSY Group Limited 6.46 Billion HKD 99.086%
JBM (Healthcare) Limited 648.41 Million HKD 90.886%
Jacobson Pharma Corporation Limited 1.46 Billion HKD 95.974%
China Resources Pharmaceutical Group Limited 270.39 Billion HKD 99.978%